Delcath begins enrollment of amended metastatic ocular melanoma registration trial
Delcath Systems announces patient enrollment has begun under the amended protocol for its registration trial in ocular melanoma liver metastases. Stanford University Medical Center is the first trial site to obtain IRB approval for the amended protocol and is open to patient enrollment. August 20, 2018